<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2</volume><submitter>Li S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-beta) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignancies, we analyzed global gene expression data to quantify PKC-beta expression across diagnostic groups and, when possible, determined correlations between PKC-beta expression and survival.&lt;h4>Results&lt;/h4>Our analysis showed that the level of PKC-beta expression was highest in chronic lymphocytic leukemia and follicular lymphoma. Within diffuse large-B cell lymphoma (DLBCL), PKC-beta expression was significantly higher in activated B-cell- like subtype than germinal center B-cell- like subtype (P &lt; 0.0001). Elevated PKC-beta appeared to be as</pubmed_abstract><journal>Biology direct</journal><pagination>8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1805741</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas.</pubmed_title><pmcid>PMC1805741</pmcid><pubmed_authors>Lahn M</pubmed_authors><pubmed_authors>Lin BK</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Phong M</pubmed_authors><pubmed_authors>Sutton S</pubmed_authors><pubmed_authors>Liao B</pubmed_authors><pubmed_authors>Thornton D</pubmed_authors><pubmed_authors>Brail L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas.</name><description>&lt;h4>Background&lt;/h4>Both mechanistic features and recent correlative findings suggest a potential role for protein kinase C-beta (PKC-beta) in tumor pathogenesis, particularly in B-cell malignancies. To evaluate the role of this gene in lymphoid malignancies, we analyzed global gene expression data to quantify PKC-beta expression across diagnostic groups and, when possible, determined correlations between PKC-beta expression and survival.&lt;h4>Results&lt;/h4>Our analysis showed that the level of PKC-beta expression was highest in chronic lymphocytic leukemia and follicular lymphoma. Within diffuse large-B cell lymphoma (DLBCL), PKC-beta expression was significantly higher in activated B-cell- like subtype than germinal center B-cell- like subtype (P &lt; 0.0001). Elevated PKC-beta appeared to be as</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Feb</publication><modification>2026-03-27T17:19:48.511Z</modification><creation>2019-03-27T02:03:30Z</creation></dates><accession>S-EPMC1805741</accession><cross_references><pubmed>17313671</pubmed><doi>10.1186/1745-6150-2-8</doi></cross_references></HashMap>